Assessment of safety after endoscopic submucosal desission in patients taking aspirin or other antithrombotic agents

Assessment of safety after endoscopic submucosal desission in patients taking aspirin or other antithrombotic agents - Assessment of safety after endoscopic submucosal desission in patients taking aspirin or other antithrombotic agents

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012079

Enrollment

100

Registered

2013-10-20

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

We perform endoscopic submucosal dissection for pationts who take some form of antithrombotic drug.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients on some form of antithrombotic therapy who underwent ESD of gastric tumor. -Patients from whom concents has been obtained to participate in this study, which has been approved by the ethics committee -Other patients who are unfit for the study as determined by the attending physician

Exclusion criteria

Exclusion criteria: Patients from whom concents has not been obtained to participate in this study, which has been approved by the ethics committee

Design outcomes

Primary

Measure	Time frame
the probability of rebleeding	—

Secondary

Measure	Time frame
the risk factor of bleeding	—

Countries

Japan

Contacts

Public ContactDaisuke Kawai

Tsuyama Chuo Hospital Department of Gastroenterology

daicawai@yahoo.co.jp0868-21-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026